Nevro (NYSE:NVRO – Get Free Report) is scheduled to be releasing its earnings data after the market closes on Tuesday, May 7th. Analysts expect Nevro to post earnings of ($1.02) per share for the quarter. Nevro has set its FY 2024 guidance at EPS and its Q1 2024 guidance at EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.
Nevro (NYSE:NVRO – Get Free Report) last released its quarterly earnings data on Wednesday, February 21st. The medical equipment provider reported ($0.15) EPS for the quarter, beating analysts’ consensus estimates of ($0.50) by $0.35. Nevro had a negative return on equity of 30.22% and a negative net margin of 21.69%. The firm had revenue of $116.18 million for the quarter, compared to analysts’ expectations of $115.93 million. On average, analysts expect Nevro to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.
Nevro Stock Up 1.3 %
NYSE:NVRO opened at $11.29 on Monday. The company has a quick ratio of 4.94, a current ratio of 6.37 and a debt-to-equity ratio of 0.72. The stock’s fifty day moving average is $13.37 and its two-hundred day moving average is $16.34. Nevro has a 52 week low of $10.27 and a 52 week high of $28.89. The stock has a market capitalization of $414.12 million, a price-to-earnings ratio of -4.39 and a beta of 0.96.
Wall Street Analysts Forecast Growth
Check Out Our Latest Analysis on Nevro
Nevro Company Profile
Nevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems.
Featured Articles
- Five stocks we like better than Nevro
- Conference Calls and Individual Investors
- MarketBeat Week in Review – 4/29 – 5/3
- Using the MarketBeat Dividend Yield Calculator
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Nevro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro and related companies with MarketBeat.com's FREE daily email newsletter.